SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xin Zhang, Xin-Rong Yang, Chao Sun, Bo Hu, Yun-Fan Sun, Xiao-Wu Huang, Zheng Wang, Yi-Feng He, Hai-Ying Zeng, Shuang-Jian Qiu, Ya Cao, Jia Fan, Jian Zhou, Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member a1 in hepatocellular carcinoma, Cancer Letters, 2015,

    CrossRef

  2. 2
    J Zhao, F Du, G Shen, F Zheng, B Xu, The role of hypoxia-inducible factor-2 in digestive system cancers, Cell Death and Disease, 2015, 6, 1, e1600

    CrossRef

  3. 3
    Garrick K. Wilson, Daniel A. Tennant, Jane A. McKeating, Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions, Journal of Hepatology, 2014, 61, 6, 1397

    CrossRef

  4. 4
    Lei Zhan, Cheng Huang, Xiao Ming Meng, Yang Song, Xiao Qin Wu, Cheng Gui Miu, Xiang Shu Zhan, Jun Li, Promising roles of mammalian E2Fs in hepatocellular carcinoma, Cellular Signalling, 2014, 26, 5, 1075

    CrossRef

  5. 5
    M Maftouh, A Avan, R Sciarrillo, C Granchi, L G Leon, R Rani, N Funel, K Smid, R Honeywell, U Boggi, F Minutolo, G J Peters, E Giovannetti, Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia, British Journal of Cancer, 2014, 110, 1, 172

    CrossRef

  6. 6
    S.-L. Yang, L.-P. Liu, J.-X. Jiang, Z.-F. Xiong, Q.-J. He, C. Wu, The Correlation of Expression Levels of HIF-1  and HIF-2  in Hepatocellular Carcinoma with Capsular Invasion, Portal Vein Tumor Thrombi and Patients' Clinical Outcome, Japanese Journal of Clinical Oncology, 2014, 44, 2, 159

    CrossRef

  7. 7
    Weihua Tian, Fenggong Cui, Miguel A Esteban, E2F1 in renal cancer: Mr Hyde disguised as Dr Jekyll?, The Journal of Pathology, 2013, 231, 2